Evidence map›Paper›PMID 38956497›Full record

ArticleCellular & molecular biology letters2024

Impairment of α-tubulin and F-actin interactions of GJB3 induces aneuploidy in urothelial cells and promotes bladder cancer cell invasion.

Junnan Liu, Xue Wang, Wencheng Jiang, Anca Azoitei, Tim Eiseler, Markus Eckstein, Arndt Hartmann, Stephan Stilgenbauer, Mohamed Elati, Meike Hohwieler and 6 more

Abstract read
In one paragraph

Article in Cellular & molecular biology letters, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Dna aneuploidy and urothelial carcinoma: A meta-analysis.Current therapeutic research, clinical and experimental · 2026
    Review
  2. Beyond the gap: moonlighting functions of connexins in cancer.Cell communication and signaling : CCS · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Junnan Liu *Department of Urology, Ulm University Hospital, Helmholtzstr. 10, 89081, Ulm, Germany.
Xue Wang *Department of Urology, Ulm University Hospital, Helmholtzstr. 10, 89081, Ulm, Germany.
Wencheng JiangDepartment of Urology, Ulm University Hospital, Helmholtzstr. 10, 89081, Ulm, Germany.
Anca AzoiteiDepartment of Urology, Ulm University Hospital, Helmholtzstr. 10, 89081, Ulm, Germany.
Tim EiselerDepartment of Internal Medicine I, Ulm University Hospital, Ulm, Germany.
Markus EcksteinInstitute of Pathology, Friedrich-Alexander University, Erlangen, Germany.
Arndt HartmannInstitute of Pathology, Friedrich-Alexander University, Erlangen, Germany.
Stephan StilgenbauerDepartment of Internal Medicine III, Ulm University, Ulm, Germany.
Mohamed ElatiCANTHER, ONCOLille Institute, University of Lille, CNRS, UMR 1277, Inserm U9020, 59045, Lille Cedex, France.
Meike HohwielerInstitute of Molecular Oncology and Stem Cell Biology, Ulm University Hospital, Ulm, Germany.
Alexander KlegerInstitute of Molecular Oncology and Stem Cell Biology, Ulm University Hospital, Ulm, Germany.
Axel JohnDepartment of Urology, Ulm University Hospital, Helmholtzstr. 10, 89081, Ulm, Germany.
Felix WezelDepartment of Urology, Ulm University Hospital, Helmholtzstr. 10, 89081, Ulm, Germany.
Friedemann ZengerlingDepartment of Urology, Ulm University Hospital, Helmholtzstr. 10, 89081, Ulm, Germany.
Christian BolenzDepartment of Urology, Ulm University Hospital, Helmholtzstr. 10, 89081, Ulm, Germany.
Cagatay GünesDepartment of Urology, Ulm University Hospital, Helmholtzstr. 10, 89081, Ulm, Germany. Cagatay.guenes@uniklinik-ulm.de.ORCID http://orcid.org/0000-0003-4301-2223

Funding

Deutsche Forschungsgemeinschaft EI792/7-1Deutsche Forschungsgemeinschaft GU569/6-1Wilhelm Sander-Stiftung 2019.038.1
6 · The paper itself

Abstract

backgroundWe have previously identified an unsuspected role for GJB3 showing that the deficiency of this connexin protein induces aneuploidy in human and murine cells and accelerates cell transformation as well as tumor formation in xenograft models. The molecular mechanisms by which loss of GJB3 leads to aneuploidy and cancer initiation and progression remain unsolved.

methodsGJB3 expression levels were determined by RT-qPCR and Western blot. The consequences of GJB3 knockdown on genome instability were assessed by metaphase chromosome counting, multinucleation of cells, by micronuclei formation and by the determination of spindle orientation. Interactions of GJB3 with α-tubulin and F-actin was analyzed by immunoprecipitation and immunocytochemistry. Consequences of GJB3 deficiency on microtubule and actin dynamics were measured by live cell imaging and fluorescence recovery after photobleaching experiments, respectively. Immunohistochemistry was used to determine GJB3 levels on human and murine bladder cancer tissue sections. Bladder cancer in mice was chemically induced by BBN-treatment.

resultsWe find that GJB3 is highly expressed in the ureter and bladder epithelium, but it is downregulated in invasive bladder cancer cell lines and during tumor progression in both human and mouse bladder cancer. Downregulation of GJB3 expression leads to aneuploidy and genomic instability in karyotypically stable urothelial cells and experimental modulation of GJB3 levels alters the migration and invasive capacity of bladder cancer cell lines. Importantly, GJB3 interacts both with α-tubulin and F-actin. The impairment of these interactions alters the dynamics of these cytoskeletal components and leads to defective spindle orientation.

conclusionWe conclude that deregulated microtubule and actin dynamics have an impact on proper chromosome separation and tumor cell invasion and migration. Consequently, these observations indicate a possible role for GJB3 in the onset and spreading of bladder cancer and demonstrate a molecular link between enhanced aneuploidy and invasive capacity cancer cells during tumor cell dissemination.

Indexed as

ActinsAneuploidyNeoplasm InvasivenessTubulinUrinary Bladder NeoplasmsAnimalsCell Line, TumorCell MovementConnexinsGenomic InstabilityHumansMiceMicrotubulesProtein BindingUrotheliumActinsConnexinsGJB3 protein, humanTubulinChromosomal imbalanceInvadopodiaMetastasisMIBCSpindle orientation

Identifiers

PMID38956497
PMCPMC11218312

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.